NHS England publishes guidance on Flash Glucose Monitors for Type 1 diabetes patients
Tens of thousands of patients with type 1 diabetes will benefit from life changing glucose monitors on the NHS from next month.
NHS England today published the clinical guidance for the monitors, outlining funding arrangements for local health groups and the criteria for who qualifies for the technology.
From April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:
- People with type 1 diabetes who need intensive monitoring (more than 8 times every day) as demonstrated in a review over the past 3 months.
- People with type 1 diabetes associated with cystic fibrosis on insulin treatment.
- Pregnant women with Type 1 Diabetes for 12 months in total.
- People with Type 1 diabetes unable to routinely self-monitor blood glucose due to disability.
- People with Type 1 diabetes for whom the specialist diabetes MDT determines have occupational or psychosocial circumstances that warrant a 6-month trial of Libre with appropriate support.
Patients will be able to receive it on prescription from their local GP or diabetes team, helping them to better manage their blood sugar level and NHS England will reimburse local health groups for costs of the wearable sensors.
The pioneering technology should ultimately help people with Type 1 diabetes achieve better health outcomes and benefits for patients include:
- Easily noticing when sugar levels are starting to rise or drop, so action can be taken earlier
- Giving patients more confidence in managing their own condition
- Not having to do as many finger-prick checks
Dr Partha Kar, Associate National Clinical Director at Diabetes said:
“This is an important step forward for the NHS and for people with type 1 diabetes.
“The guidance published today confirms the NHS’ commitment to improving the care of those with type 1 diabetes and signals an end to the variation in availability to the life changing technology.”
JDRF Chief Executive Officer in the UK, Karen Addington said:
“We are delighted that these new guidelines will effectively end the inequity of access to Flash Glucose Monitoringthat people living with type 1 diabetes have experienced, based simply on where they live in England. JDRF has worked with NHS England and partners to secure this outcome and look forward to supporting the implementation in April.”
Of those with a diagnosis of diabetes, an estimated 260,000 in England have Type 1 diabetes.
Latest News from
Pre-election guidance for the 2019 General Election07/11/2019 16:15:00
This pre-election guidance will help organisations make all staff aware of the implications on communications activities of the period prior to the 2019 general election.
New NHS online training to help people get home from hospital quicker05/11/2019 16:51:00
NHS England and Health Education England have today launched ActNow, an e-learning tool developed for health service and care staff to help them reduce hospital delays for patients.
Demand for NHS burns care soars over bonfire night and diwali04/11/2019 14:15:00
Top doctors from the NHS and St John Ambulance have teamed up to urge revellers to stay safe during Guy Fawkes Night and Diwali celebrations, as new figures reveal thousands end up in hospital each year due to firework and bonfire injuries.
Public back NHS plans for new rapid care measures01/11/2019 14:25:00
England’s top doctor has welcomed new polling showing that patients and the public support NHS proposals focussing on fast treatment for those who need it in A&E.
NHS ramps up drive to increase uptake of lifesaving vaccines28/10/2019 09:15:00
More lifesaving vaccines should be provided in convenient locations for parents to drive uptake, a new NHS review shows.
NHS England concludes wide-ranging deal for cystic fibrosis drugs24/10/2019 12:20:00
NHS England has today announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines.
Tens of thousands given life changing diabetes monitors thanks to the NHS Long Term Plan22/10/2019 14:15:00
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan.
World Antibiotic Awareness Week, 18-22 November22/10/2019 09:15:00
World Antibiotic Awareness Week (WAAW) aims to increase awareness of antibiotic resistance as a global problem, and to promote best practices among the general public, health workers and policy-makers to avoid the further emergence and spread of antibiotic resistance.